BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32859154)

  • 1. Plasma trimethylamine n-oxide is associated with renal function in patients with heart failure with preserved ejection fraction.
    Guo F; Qiu X; Tan Z; Li Z; Ouyang D
    BMC Cardiovasc Disord; 2020 Aug; 20(1):394. PubMed ID: 32859154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimethylamine N-Oxide is Associated with Heart Failure Risk in Patients with Preserved Ejection Fraction.
    Dong Z; Zheng S; Shen Z; Luo Y; Hai X
    Lab Med; 2021 Jul; 52(4):346-351. PubMed ID: 33135738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal function is associated with plasma trimethylamine-N-oxide, choline, L-carnitine and betaine: a pilot study.
    Guo F; Dai Q; Zeng X; Liu Y; Tan Z; Zhang H; Ouyang D
    Int Urol Nephrol; 2021 Mar; 53(3):539-551. PubMed ID: 32945995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.
    Winther SA; Øllgaard JC; Tofte N; Tarnow L; Wang Z; Ahluwalia TS; Jorsal A; Theilade S; Parving HH; Hansen TW; Hazen SL; Pedersen O; Rossing P
    Diabetes Care; 2019 Aug; 42(8):1512-1520. PubMed ID: 31123156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of a Novel Diagnostic Biomarker, the Plasma Cardiac Bridging Integrator 1 Score, With Heart Failure With Preserved Ejection Fraction and Cardiovascular Hospitalization.
    Nikolova AP; Hitzeman TC; Baum R; Caldaruse AM; Agvanian S; Xie Y; Geft DR; Chang DH; Moriguchi JD; Hage A; Azarbal B; Czer LS; Kittleson MM; Patel JK; Wu AHB; Kobashigawa JA; Hamilton M; Hong T; Shaw RM
    JAMA Cardiol; 2018 Dec; 3(12):1206-1210. PubMed ID: 30383171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.
    Lee Y; Nemet I; Wang Z; Lai HTM; de Oliveira Otto MC; Lemaitre RN; Fretts AM; Sotoodehnia N; Budoff M; DiDonato JA; McKnight B; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
    J Am Heart Assoc; 2021 Sep; 10(17):e020646. PubMed ID: 34398665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota-derived trimethylamine N-oxide is associated with poor prognosis in patients with heart failure.
    Li W; Huang A; Zhu H; Liu X; Huang X; Huang Y; Cai X; Lu J; Huang Y
    Med J Aust; 2020 Oct; 213(8):374-379. PubMed ID: 32959366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiographic and Hemodynamic Parameters Associated with Diminishing Renal Filtration among Patients with Heart Failure with Preserved Ejection Fraction.
    Lo KB; Mezue K; Ram P; Goyal A; Shah M; Krishnamoorthy P; Gupta S; Pressman GS; Rangaswami J
    Cardiorenal Med; 2019; 9(2):83-91. PubMed ID: 30544108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse Renal Response to Decongestion in the Obese Phenotype of Heart Failure With Preserved Ejection Fraction.
    Reddy YNV; Obokata M; Testani JM; Felker GM; Tang WHW; Abou-Ezzeddine OF; Sun JL; Chakrabothy H; McNulty S; Shah SJ; Lewis GD; Stevenson LW; Redfield MM; Borlaug BA
    J Card Fail; 2020 Feb; 26(2):101-107. PubMed ID: 31618698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and prognostic influence of renal dysfunction in heart failure patients with preserved ejection fraction.
    Casado J; Montero M; Formiga F; Carrera M; Urrutia A; Arévalo JC; Pérez-Calvo JI;
    Eur J Intern Med; 2013 Oct; 24(7):677-83. PubMed ID: 23830876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethylamine N-oxide and outcomes in patients hospitalized with acute heart failure and preserved ejection fraction.
    Kinugasa Y; Nakamura K; Kamitani H; Hirai M; Yanagihara K; Kato M; Yamamoto K
    ESC Heart Fail; 2021 Jun; 8(3):2103-2110. PubMed ID: 33734604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional value of Galectin-3 to BNP in acute heart failure patients with preserved ejection fraction.
    Beltrami M; Ruocco G; Dastidar AG; Franci B; Lucani B; Aloia E; Nuti R; Palazzuoli A
    Clin Chim Acta; 2016 Jun; 457():99-105. PubMed ID: 27067445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control.
    Mueller DM; Allenspach M; Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A
    Atherosclerosis; 2015 Dec; 243(2):638-44. PubMed ID: 26554714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of estimated plasma volume reduction on renal function for acute heart failure differs between patients with preserved and reduced ejection fraction.
    Takei M; Kohsaka S; Shiraishi Y; Goda A; Izumi Y; Yagawa M; Mizuno A; Sawano M; Inohara T; Kohno T; Fukuda K; Yoshikawa T;
    Circ Heart Fail; 2015 May; 8(3):527-32. PubMed ID: 25737498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors and Prognostic Value of Worsening Renal Function During Admission in HFpEF Versus HFrEF: Data From the KorAHF (Korean Acute Heart Failure) Registry.
    Kang J; Park JJ; Cho YJ; Oh IY; Park HA; Lee SE; Kim MS; Cho HJ; Lee HY; Choi JO; Hwang KK; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29535141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of renal resistance index and arterial stiffness on clinical outcomes in patients with mild-to-moderate renal dysfunction and presence or absence of heart failure with preserved ejection fraction.
    Aizawa Y; Okumura Y; Saito Y; Ikeya Y; Nakai T; Arima K
    Heart Vessels; 2020 Dec; 35(12):1699-1708. PubMed ID: 32591893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between Plasma Trimethylamine N-Oxide Levels and Renal Dysfunction in Patients with Hypertension.
    Zhou J; Wang D; Li B; Li X; Lai X; Lei S; Li N; Zhang X
    Kidney Blood Press Res; 2021; 46(4):421-432. PubMed ID: 34233325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of Trimethylamine-N-Oxide in Chronic Kidney Disease: Contribution of Decreased Glomerular Filtration Rate.
    Pelletier CC; Croyal M; Ene L; Aguesse A; Billon-Crossouard S; Krempf M; Lemoine S; Guebre-Egziabher F; Juillard L; Soulage CO
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31683880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
    Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
    Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Systemic Trimethyllysine With Heart Failure With Preserved Ejection Fraction and Cardiovascular Events.
    Wei H; Zhao M; Wu J; Li C; Huang M; Gao J; Zhang Q; Ji L; Wang Y; Zhao C; Dong E; Zheng L; Wang DW
    J Clin Endocrinol Metab; 2022 Nov; 107(12):e4360-e4370. PubMed ID: 36062477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.